Lai Wang - 09 Sep 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: Global Head of R&D
Issuer ticker: ONC
Reported as of: 09 Sep 2025
Net transaction value: -$1,750,312
SEC form: 4
Accepted by SEC: 11 Sep 2025, 17:10:50 UTC
Prior SEC filing: 31 Jul 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Lai Wang filed Form 4 for BeOne Medicines Ltd. (ONC) on 11 Sep 2025.

Key facts

This page summarizes Lai Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Sep 2025, 17:10.

Change

Previous filing in this sequence was filed on 31 Jul 2025.
Current net transaction value: -$1,750,312.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001852291 Primary reporting owner

Wang Lai

Relationship: Global Head of R&D
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 11 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

American Depositary Shares

Sale

Transaction value: $1,750,312
Shares: -5,000
Change %: -100%
Price: $350.06
Shares after: 0
Date: 09 Sep 2025
Ownership: See Footnote
Footnotes: F1, F5, F6, F7

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,023,529
Date: 09 Sep 2025
Ownership: Direct

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 601,965
Date: 09 Sep 2025
Ownership: See Footnote
Footnotes: F1

ONC holding

RMB Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 09 Sep 2025
Ownership: See Footnote
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership.

Footnote F2

The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market.

Footnote F3

The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

Footnote F4

The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB10 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

Footnote F5

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F6

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2024.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.